Based on immune checkpoint inhibitor to improve cancer treatment

Abstract

Different kinds of cancer normally have enormous prognosis according to its kind and different therapeutic methods. Sometimes use approprete treatment can get better prognosis, tradinional therapeutic such as chemotherapy, radiotherapy are notsuitable for some patients. Cancer cure is always a hot issue for scientists to think about, as growing population of cancer patients every year. Immune checkpoint therapy (ICT) has a significant advantage for its high accuracy. For patients with immune system related kind of cancer are most likely to benefit from its high precision. NSCLC patients, TNBC patients and people who got HER2-positive advanced gastric cancer thes specific types of have different reasons for bad result, but the basic factors are low response to chemotherapy. As treatment for some types of cancer has encountered with block, some types are hard to react to chemotherapy and some have lower mOS. Some patients have badly side effects compare with other, and the drug-fast problem is significant. For better result scientists believe ICT can activated immune system and keep its natural power in killing cancer cells. As more combination therapies of ICIs proposed in the future cancer patients are diffinatly have more chance. In conclution, ICT is a powerful way to heal cancer patients, and for many sevier patients this maybe their best chiose. ICT still need futher improvement to deal with more different kinds of cancer and reduce the side effects that it causes but its high efficiency is a good news for people who got cancer.